Deal overview
| Target | MEDICINES COMPANY (THE) |
|---|---|
| Bidder | NOVARTIS AG |
| Price | £0.00 Full version or £25.00 Light version |
| Publication Date | Nov 24, 2019 |
| Abstract | On 24 November 2019, it was announced that the quoted Swiss pharmaceuticals group Novartis AG was to make a recommended cash offer to acquire "The Medicines Company", a Nasdaq listed pharmaceuticals business. According to the two companies, the offer of US$85 in cash per share implied a fully diluted equity value for The Medicines Company of US$9.7 billion. The offer would be ... |
| Number of pages (Full version) | 0 |
| Number of pages (Light version) | 2 |
| Format | Adobe Acrobat (Download Acrobat Reader) |
| Free Sample | Click Here to Download |
Purchase this report
Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.
©2024 M&A Monitor Limited
